Search results for "Systemic."

showing 10 items of 756 documents

Analysis of Epitope Spreading over an Eleven-year Period in a Patient with Systemic Lupus Erythematosus: CASE REPORT

1998

During a period of more than eleven years serum samples of a patient with Systemic Lupus Erythematosus were collected and analyzed for anti-nuclear autoantibodies. High titer of anti-La/SS-B were detectable in all serum samples. The La/SS-B epitopes remained constant. Besides anti-La/SS-B antibodies all serum samples contained traces of anti-Ro/SS-A including anti-Ro52 and anti-Ro60 antibodies. During disease flares anti-Ro/SS A antibodies were upregulated and anti-dsDNA antibodies appeared, thus supporting the concept of an antigen driven intermolecular epitope spreading to Ro/SS-A and dsDNA.

Systemic diseaseLupus erythematosusAnti-nuclear antibodybiologybusiness.industryImmunologyGeneral Medicinemedicine.diseasemedicine.disease_causeEpitopeAutoimmunityEpitope mappingRheumatologyAntigenImmunologymedicinebiology.proteinImmunology and AllergyAntibodyskin and connective tissue diseasesbusinessScandinavian Journal of Rheumatology
researchProduct

Beryllium-induced disturbances of the murine immune system reflect some phenomena observed in sarcoidosis.

1994

Sarcoidosis is a systemic granulomatous disorder of unknown origin. In respect to clinical and immunological characteristics, it is indistinguishable from berylliosis. As an approach to develop a murine model reflecting some aspects of sarcoidosis, we attempted to induce berylliosis in mice by treating inbred F1 mice (C57B16 x DBA/2) with 3 mg beryllium sulfate (BeSO4) per kg body weight intraperitoneally. Either pure BeSO4 or BeSO4 in combination with incomplete Freund's adjuvant was administered. Alternatively, pure BeSO4 was injected 2 days after a single application of cyclophosphamide (150 mg/kg). The spleen index, the spontaneous and phorbolmyristate acetate (PMA)-induced radical oxyg…

Systemic diseasePathologymedicine.medical_specialtySarcoidosisBerylliosisT-LymphocytesImmunologyMuriBiologyLymphocyte ActivationBerylliosisMiceImmune systemAnimal modelMacrophages AlveolarmedicineImmunology and AllergyGranulomatous disorderMacrophageAnimalsHumansGeneral Medicinemedicine.diseaseMice Inbred C57BLMice Inbred DBAImmune SystemImmunologyMacrophages PeritonealFemaleSarcoidosisBerylliumReactive Oxygen SpeciesSpleenInternational archives of allergy and immunology
researchProduct

The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence

2020

Alzheimer’s disease (AD) is a fatal form of dementia of unknown etiology. Although amyloid plaque accumulation in the brain has been the subject of intensive research in disease pathogenesis and anti-amyloid drug development; the continued failures of the clinical trials suggest that amyloids are not a key cause of AD and new approaches to AD investigation and treatment are needed. We propose a new hypothesis of AD development based on metabolic abnormalities in circulating red blood cells (RBCs) that slow down oxygen release from RBCs into brain tissue which in turn leads to hypoxia-induced brain energy crisis; loss of neurons; and progressive atrophy preceding cognitive dysfunction. This …

Systemic diseaselcsh:MedicineBrain tissueDiseaseReview03 medical and health sciences0302 clinical medicinebrain energy crisismedicineDementiaerythrocytic hypothesis030304 developmental biology0303 health sciencesbusiness.industrylcsh:RNeurodegenerationGeneral Medicinemedicine.diseaserestoration of energy metabolismDrug developmentamyloid β peptidesEtiologyAlzheimer's diseasebusinessNeuroscienceAlzheimer’s disease030217 neurology & neurosurgeryred blood cellsJournal of Clinical Medicine
researchProduct

S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academ…

2016

Cutaneous lupus erythematosus (CLE) is a rare inflammatory autoimmune disease with heterogeneous clinical manifestations. To date, no therapeutic agents have been licensed specifically for patients with this disease entity, and topical and systemic drugs are mostly used 'off-label'. The aim of the present guideline was to achieve a broad consensus on treatment strategies for patients with CLE by a European subcommittee, guided by the European Dermatology Forum (EDF) and supported by the European Academy of Dermatology and Venereology (EADV). In total, 16 European participants were included in this project and agreed on all recommendations. Topical corticosteroids remain the mainstay of trea…

Systemic diseasemedicine.medical_specialtyVenereologyConsensusCalcineurin InhibitorsDermatologyDapsone030207 dermatology & venereal diseases03 medical and health sciencesAntimalarialsRetinoids0302 clinical medicineAdrenal Cortex HormonesmedicineLupus Erythematosus CutaneousHumans610 Medicine & healthlupus erythematous cuteneous guidelines treatmentLenalidomideLenalidomide030203 arthritis & rheumatologyBiological ProductsLupus erythematosusbusiness.industryfungiGuidelineMycophenolic Acidmedicine.diseaseDermatologyThalidomideClinical trialThalidomideInfectious DiseasesMethotrexatePractice Guidelines as TopicbusinessDapsoneImmunosuppressive Agentsmedicine.drug
researchProduct

MRT des Herzens bei Verdacht auf Myokarditis

2002

Purpose To evaluate the potential of ECG-gated breath-hold MRI in diagnosing acute myocarditis. Material and methods Cardiac MRI was performed on 21 consecutive patients with suspected myocarditis. ECG-gated breath-hold T2-weighted images with fat suppression were acquired in 3 standard views. T1-weighted imaging (FLASH) was performed 10 min after IV administration of Gd-DTPA. Laboratory data included creatine kinase, troponin T and serological tests, ECG findings and echocardiography. Imaging findings were retrospectively compared to the discharge diagnoses. Signal alterations were semiquantitatively classified. Results Acute myocarditis was diagnosed in 9 patients and cardiac sarcoidosis …

Systemic diseasemedicine.medical_specialtyViral MyocarditisMyocarditisTroponin Tmedicine.diagnostic_testbiologybusiness.industryMagnetic resonance imagingmedicine.diseaseInternal medicinemedicinebiology.proteinCardiologyRadiology Nuclear Medicine and imagingCreatine kinaseSarcoidosisNuclear medicinebusinessElectrocardiographyRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

P609 New and old criteria for diagnosing celiac disease

2019

Background CD is an immune-mediated systemic disease elicited by gluten and related prolamines, it affects genetically susceptible individuals and it is characterized by the presence of gluten-dependent clinical manifestations, CD-specific antibodies, HLA-DQ2 or HLA-DQ8 haplotypes and enteropathy. According to the guidelines published by ESPGHAN in 2012, it is possible to diagnose celiac disease without intestinal biopsy, in symptomatic children and adolescents with very high levels of transglutaminases type-2 antibodies and positive HLA DQ2/DQ8. Aims The aim of our study is to analyse two groups of patients: one in which diagnosis was based on the new ESPGHAN criteria, and another based on…

Systemic diseasemedicine.medical_specialtybusiness.industryIncidence (epidemiology)HLA-DQ2nutritional and metabolic diseasesDiseasemedicine.diseaseThyroiditisSerologyInternal medicinemedicineEnteropathybusinessPediatric gastroenterologyAbstracts
researchProduct

How to manage patients with polyvascular atherosclerotic disease. Position paper of the International Union of Angiology

2020

Atherosclerosis is a systemic disease affecting multiple arterial territories. Patients with clinical atherosclerotic disease in one vascular bed are likely to have asymptomatic or symptomatic atherosclerotic lesions in other vascular beds. Specifically, peripheral arterial disease (PAD) often coexists with coronary and carotid disease. With progression of atherosclerotic disease in one vascular bed, the risk of clinical manifestations in other territories increases and the incidence of adverse cardiovascular events increases substantially with the number of affected vascular beds. Classical risk factors are associated with the development of polyvascular atherosclerotic disease (PVD) in di…

Systemic diseasemedicine.medical_specialtymedicine.medical_treatmentCardiologyDisease030204 cardiovascular system & hematology030230 surgeryRevascularizationAsymptomaticPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineRisk FactorsmedicineHumansIntensive care medicineAngiologybusiness.industryIncidence (epidemiology)GuidelineAtherosclerosismedicine.diseasePosition papermedicine.symptomCardiology and Cardiovascular MedicinebusinessInternational Angiology
researchProduct

Challenges concerning argumentative writing in a second language context

2018

The current study is based on parts of the data collected in a quasi-experiment conducted in four English classes of Norwegian upper secondary school students. The purpose of the quasi-experiment was to explore whether a teaching intervention based on systemic functional linguistics and genre-pedagogy would support students in improving their competence in writing argumentative texts in English. The improvement was measured by comparing evaluations of pre-and post-tests. The current study investigates what seemed to be the main challenges for Norwegian students concerning this type of genre in a second language context based on the pre-tests and the evaluations of the pre-tests. The most ch…

Systemic functional linguisticsArgumentativeSecond language writingSecond languagelanguageMathematics educationNorwegianFormalityPsychologyCompetence (human resources)language.human_languageArgumentation theoryNordic Journal of Modern Language Methodology
researchProduct

The relationship between BAFF serum levels, anti-NMDAR autoantibodies and fatigue in patients with systemic lupus erythematosus and multiple sclerosi…

2020

Systemic lupus erythematosusMultiple Sclerosisbusiness.industryMultiple sclerosisImmunologyAutoantibodymedicine.diseaseImmunologyB-Cell Activating FactormedicineImmunology and AllergyNMDA receptorHumansLupus Erythematosus SystemicIn patientB-cell activating factorbusinessFatigueAutoantibodiesAutoimmunity reviews
researchProduct

T-cell hyperreactivity of NZB mice against H-2 identical cells

1983

NZB mice serve as a model for human systemic lupus erythematodes. T-cell abnormalities in this strain have previously been described. In this paper the cytotoxic T lymphocyte precursor (CTL-p) frequencies of NZB mice against H-2 allogeneic and H-2 syngeneic cells are investigated and compared with those of the normal strain BALB/c. The CTL-p frequency in NZB lymphocytes against H-2 allogeneic cells equals that in normal mouse strains (i.e. 1/7500). The NZB anti BALB/c response is in the same order of magnitude. No corresponding BALB/c anti NZB response was elicited. The results suggest abnormally high sensitivity of NZB CTL-p to helper signals.

T cellImmunologychemical and pharmacologic phenomenaurologic and male genital diseasesMiceRheumatologyimmune system diseasesAnimalsLupus Erythematosus SystemicImmunology and AllergyCytotoxic T cellMedicineskin and connective tissue diseasesMice Inbred BALB CMice Inbred NZBStrain (chemistry)business.industrySystemic lupusT-Lymphocytes Helper-InducerDisease Models AnimalCTL*medicine.anatomical_structureCytotoxic T-lymphocyte precursor frequencyImmunologybusinessT-Lymphocytes CytotoxicRheumatology International
researchProduct